Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial)
Mamun Al Mahtab, Morikazu Onji(Ehime University), Sheikh Mohammad Fazle Akbar(Tokyo Shinagawa Hospital), Ángela Tuero(Centro de Ingeniería Genética y Biotecnología), E Penton(Centro de Ingeniería Genética y Biotecnología), Julio Aguilar(Centro de Ingeniería Genética y Biotecnología), Osamu Yoshida(Ehime University Hospital), Gerardo Guillén(Hunan City University), Yoichi Hiasa(Ehime University Hospital)
Cited by 94
Related Papers
Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors
|Oncogene|1999|693
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
A Glycine-rich RNA-binding Protein Mediating Cold-inducible Suppression of Mammalian Cell Growth
|The Journal of Cell Biology|1997|388
Detection of urovirulence factors in<i>Escherichia coli</i>by multiplex polymerase chain reaction
|FEMS Immunology & Medical Microbiology|1995|317